CELLBUILDER
Live / Applied — Statement of use — non-final action mailed (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 26 Apr 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99156741
- Mark type
- Stylized text
- Filed
- 26 Apr 2025
- Published for opposition
- 14 Oct 2025
- Attorney of record
- Brian B. Darville
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceuticals for cell and gene therapies
- Class 045 — Legal and security services: Regulatory compliance consulting in the field of pharmaceuticals
Owner
- Childrens National Hospital, Washington, DC, US
- Childrens National Hospital, Washington, DC, US
Prosecution history
- 09 Sept 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Sept 2026 — NON-FINAL ACTION E-MAILED
- 09 Sept 2026 — SU - NON-FINAL ACTION - WRITTEN
- 19 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jun 2026 — USE AMENDMENT FILED
- 18 Aug 2026 — SOU EXTENSION 1 GRANTED
- 02 Jun 2026 — SOU EXTENSION 1 FILED
- 17 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 29 May 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 May 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 May 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 May 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED